| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| DEC TIMOTHY C | Senior Vice-President & CFO | C/O SUPERNUS PHARMACEUTICALS, INC., 9715 KEY WEST AVENUE, ROCKVILLE | /s/ Timothy C. Dec | 25 Feb 2026 | 0001194020 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SUPN | Common Stock | Award | $0 | +1,125 | +69% | $0.000000 | 2,763 | 24 Feb 2026 | Direct | |
| transaction | SUPN | Common Stock | Tax liability | $30,964 | -603 | -22% | $51.35 | 2,160 | 24 Feb 2026 | Direct | F1 |
| transaction | SUPN | Common Stock | Award | $0 | +500 | +23% | $0.000000 | 2,660 | 24 Feb 2026 | Direct | |
| transaction | SUPN | Common Stock | Tax liability | $12,308 | -242 | -9.1% | $50.86 | 2,418 | 24 Feb 2026 | Direct | F1 |
| transaction | SUPN | Common Stock | Award | $0 | +3,000 | +124% | $0.000000 | 5,418 | 24 Feb 2026 | Direct | |
| transaction | SUPN | Common Stock | Tax liability | $77,511 | -1,524 | -28% | $50.86 | 3,894 | 24 Feb 2026 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SUPN | Restricted Stock Unit | Disposed to Issuer | $0 | -1,125 | -25% | $0.000000 | 3,375 | 24 Feb 2026 | Common Stock | 1,125 | Direct | F2, F3 | |
| transaction | SUPN | Restricted Stock Unit | Disposed to Issuer | $0 | -500 | -100% | $0.000000 | 0 | 24 Feb 2026 | Common Stock | 500 | Direct | F2, F4 | |
| transaction | SUPN | Restricted Stock Unit | Disposed to Issuer | $0 | -3,000 | -33% | $0.000000 | 6,000 | 24 Feb 2026 | Common Stock | 3,000 | Direct | F2, F5 |
| Id | Content |
|---|---|
| F1 | Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. |
| F2 | Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. |
| F3 | These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 19, 2026. |
| F4 | These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023. |
| F5 | These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025. |